The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Healthy Adults
Interventions
DRUG

Prednisone

Subjects will receive oral prednisone and/or placebo tablets (total of 4 tablets) to achieve the required dose according to the treatment sequence group they were randomized. Subjects are to be dosed each morning for 7 days. A 14 day washout period is required between each period. Prednisone was supplied in the 2.5 and 20 mg dosage strengths.

DRUG

Placebo

Placebo tablets similar to Prednisone 2.5 mg and 20 mg were supplied to make the trial doses.

Trial Locations (1)

49007

Jasper Clinic, Inc., Kalamazoo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02767089 - The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers | Biotech Hunter | Biotech Hunter